8 results for author:"Worton R.G." in Literature citations
Results Customize
› Repeat search in UniProtKB (12)
| The mouse dystrophin muscle promoter/enhancer drives expression of mini-dystrophin in transgenic mdx mice and rescues the dystrophy in these mice. Anderson C.L., De Repentigny Y., Cifelli C., Marshall P., Renaud J.M., Worton R.G., Kothary R. Mol. Ther. 14:724-734(2006) · Mapped (69) |
| The mouse dystrophin muscle enhancer-1 imparts skeletal muscle, but not cardiac muscle, expression onto the dystrophin Purkinje promoter in transgenic mice. De Repentigny Y., Marshall P., Worton R.G., Kothary R. Hum. Mol. Genet. 13:2853-2862(2004) · Mapped (10) |
| Mouse dystrophin enhancer preferentially targets lacZ expression in skeletal and cardiac muscle. Marshall P., Chartrand N., De Repentigny Y., Kothary R., Pelletier L., Mueller R., Worton R.G. Dev. Dyn. 224:30-38(2002) · Mapped (10) |
| Localization of the mdx mutation within the mouse dystrophin gene. Ryder-Cook A.S., Sicinski P., Thomas K., Davies K.E., Worton R.G., Barnard E.A., Darlison M.G., Barnard P.J. EMBO J. 7:3017-3021(1988) · Mapped (31) |
| Age-related conversion of dystrophin-negative to -positive fiber segments of skeletal but not cardiac muscle fibers in heterozygote mdx mice. Karpati G., Zubrzycka-Gaarn E.E., Carpenter S., Bulman D.E., Ray P.N., Worton R.G. J. Neuropathol. Exp. Neurol. 49:96-105(1990) · Mapped (8) |
| Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. MacLennan D.H., Duff C., Zorzato F., Fujii J., Phillips M., Korneluk R.G., Frodis W., Britt B.A., Worton R.G. Nature 343:559-561(1990) · Mapped (2) |
| A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia. Gillard E.F., Otsu K., Fujii J., Khanna V.K., de Leon S., Derdemezi J., Britt B.A., Duff C.L., Worton R.G., MacLennan D.H. Genomics 11:751-755(1991) · UniProtKB (1) |
| Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor (RYR1) gene in individuals with malignant hyperthermia. Gillard E.F., Otsu K., Fujii J., Duff C.L., de Leon S., Khanna V.K., Britt B.A., Worton R.G., McLennan D.H. Genomics 13:1247-1254(1992) · UniProtKB (1) |